Atlantic Investment Company’s Pfizer PFE Stock Holding History

Atlantic Investment Company’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$305K	Hold	10,222	–	–	0.89%	37
2015 Q2	$325K	Sell	10,222 -532	-5%	-$17.3K	0.78%	38
2015 Q1	$355K	Hold	10,754	–	–	0.7%	39
2014 Q4	$318K	Buy	+10,754	New	+$308K	0.45%	38
2014 Q3	–	Sell	-10,754	Closed	-$302K	–	44
2014 Q2	$303K	Sell	10,754 -511	-5%	-$14.6K	0.26%	44
2014 Q1	$343K	Sell	11,265 -106	-0.9%	-$3.16K	0.33%	43
2013 Q4	$330K	Sell	11,371 -848	-7%	-$24.7K	0.29%	42
2013 Q3	$333K	Buy	12,219 +443	+4%	+$12.1K	0.22%	43
2013 Q2	$313K	Buy	+11,776	New	+$325K	0.23%	44

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Atlantic Investment Company's PFE Position: Q3 2015 in Review

Atlantic Investment Company held its Pfizer (PFE) position steady in Q3 2015 at 10,222 shares worth $305K. The position accounts for 0.89% of the portfolio, ranked #37.

Atlantic Investment Company first reported a position in PFE in Q2 2013 and has held it in 9 quarters since. The position peaked at $355K in Q1 2015. 1,879 funds tracked by Wall St. Rank hold PFE as of Q3 2015.

Atlantic Investment Company held 10,222 shares of Pfizer worth $305K as of Q3 2015.
Atlantic Investment Company left its Pfizer share count unchanged in Q3 2015.
Pfizer made up 0.89% of Atlantic Investment Company's portfolio in Q3 2015, its #37 holding.
Atlantic Investment Company first reported a position in Pfizer in Q2 2013 and has held it in 9 quarters since.
Atlantic Investment Company's Pfizer position peaked at $355K in Q1 2015.
1,879 funds tracked by Wall St. Rank held Pfizer as of Q3 2015.

Based on Atlantic Investment Company's 13F filing for Q3 2015, filed 13 Nov 2015.